April 23 (Reuters) - Pharma Mar SA PHMR.MC :
* AUSTRALIAN THERAPEUTIC GOODS ADMINISTRATION (TGA) APPROVES YONDELIS FOR SOFT TISSUE SARCOMA
* APPROVAL WAS BASED ON CLINICAL EFFICACY AND SAFETY DATA FROM A PHASE 3, RANDOMIZED, OPEN-LABEL, CONTROLLED STUDY
* THIS PIVOTAL TRIAL CONFIRMED THE RESULTS OF PREVIOUS CLINICAL STUDIES AND PROVIDES STRONG EVIDENCE OF CLINICAL BENEFIT OF TRABECTEDIN